AFP14 小时
CHMP Recommends Approval of Galderma’s Nemolizumab for Moderate-to-Severe Atopic ...
This positive CHMP opinion is based on robust results from the phase III ARCADIA and OLYMPIA clinical trial programs in atopic dermatitis and prurigo nodularis, respectively. The phase III ARCADIA 1 ...